Subject(s)
Abnormalities, Multiple , Urogenital Abnormalities , Abnormalities, Multiple/classification , Anus, Imperforate , Face/abnormalities , Fatal Outcome , Female , Humans , Infant, Newborn , Karyotyping , Lumbar Vertebrae/abnormalities , Phenotype , Syndrome , Thoracic Vertebrae/abnormalitiesSubject(s)
Musculoskeletal Diseases/epidemiology , Adolescent , Adult , Aged , Child , Global Health , HumansSubject(s)
Pathology, Oral/trends , Adult , Attitude of Health Personnel , Career Choice , Education, Dental, Graduate , Education, Medical , Employment , Female , Forecasting , Humans , International Cooperation , Internship and Residency , Laboratories, Dental/trends , Male , Pathology, Oral/education , Pathology, Oral/statistics & numerical data , Professional Practice/trends , United StatesSubject(s)
Acid-Base Imbalance/diagnosis , Calcinosis/diagnosis , Dyspnea/etiology , Kidney Failure, Chronic/complications , Uremia/diagnosis , Water-Electrolyte Imbalance/diagnosis , Acid-Base Imbalance/blood , Acid-Base Imbalance/therapy , Adult , Calcinosis/blood , Calcinosis/complications , Dyspnea/blood , Fatal Outcome , Female , Humans , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/therapy , Multiple Organ Failure/blood , Multiple Organ Failure/etiology , Renal Dialysis , Water-Electrolyte Imbalance/blood , Water-Electrolyte Imbalance/therapyABSTRACT
BACKGROUND/AIMS: To determine the alterations in coagulation and fibrinolysis occurring in patients treated with the liver dialysis device. METHODOLOGY: Patients with advanced liver disease treated with the liver dialysis device were studied immediately before and after the liver dialysis device treatment. SETTING: A university hospital intensive care unit. PATIENTS: Thirteen consecutive patients with advanced liver disease being evaluated for or awaiting liver transplantation. INTERVENTION: 4-6 hours of liver dialysis treatment for management of hepatic encephalopathy. OUTCOME MEASURES: A panel of coagulation and anticoagulation factors, as well as fibrinolytic and anti-fibrinolytic factors plus measures of activation of inflammation and soluble adhesion factors. RESULTS: The liver dialysis device used was found to be associated with activation of both coagulation and fibrinolytic pathways, activation of inflammation reactants, and an increase in sL-selectin levels. CONCLUSIONS: Liver dialysis device activates both coagulant and fibrinolytic pathways, activates inflammatory response, but these responses are limited to the vascular compartment by an increase in sL-selectin levels.
Subject(s)
Fibrinolysis , Hemofiltration/methods , Hemostasis , Liver Diseases/therapy , Aged , Biomarkers , Blood Coagulation , Dialysis/instrumentation , Female , Hemofiltration/instrumentation , Humans , Liver Diseases/physiopathology , Male , Middle AgedABSTRACT
BACKGROUND: Ipsilateral salivary gland tumors of different histologic types are rare and make up less than 0.3% of all salivary gland neoplasms. Only nine cases of synchronous benign and malignant ipsilateral parotid gland tumors have been described in the literature. METHODS: Two additional cases of synchronous benign and malignant neoplasms in the parotid gland are reported and discussed with a review of literature. RESULTS: Our first case describes a pleomorphic adenoma and a salivary duct carcinoma, an entity not previously reported in the literature. The second case documents the most common benign and malignant ipsilateral parotid gland neoplasm reported in this case series, a Warthin's tumor and a mucoepidermoid carcinoma. CONCLUSIONS: Synchronous salivary gland tumors exhibiting both benign and malignant components are uncommonly observed, with only nine cases published to date. We describe two additional cases of a synchronous benign and malignant ipsilateral parotid gland tumor.
